Rybińska M, Rzepka H, Stępowski P, Tajster M. Tirzepatide vs. Cagrilintide/Semaglutide: A New Frontier in Pharmacological Management of Obesity. J Educ Health Sport [Internet]. 2026 Sep. 20 [cited 2026 Oct. 3];95:73651. Available from: https://apcz.umk.pl/JEHS/article/view/73651